Sculptra is reconstituted by your treating practitioner and injected into the skin to increase the volume of depressed areas, particularly to correct skin depressions, such as in skin creases, wrinkles, folds, scars and for skin aging.
During your consultation, you will be given the opportunity to ask questions and have received satisfactory answers to your questions.
In particular, you will received information regarding when treatment with Sculptra® should not take place and have also been informed of precautions, warnings for use with these products and common injection related reactions.
Sculptra is an FDA-approved injectable treatment designed to restore facial volume lost due to aging or illness. Unlike traditional dermal fillers, Sculptra is made from poly-L-lactic acid (PLLA), a biocompatible substance that stimulates your body’s natural collagen production. It gradually improves skin structure and firmness over time, making it ideal for those seeking subtle, long-lasting rejuvenation.
EXPECTED OUTCOME
Sculptra provides natural-looking results that emerge gradually over several weeks. Most clients see noticeable improvements in skin texture, volume, and contour after a series of treatments—typically 2 to 4 sessions spaced several weeks apart. The full effects can last up to 2 years or more, as collagen continues to build.
COMMON INJECTION REACTIONS
* Itching
* Pain
* Transient bleeding
* Redness or swelling in the treatment area.
* Swelling at the injection site
* Mild bruising
* Small lumps under the skin (usually temporary and resolve on their own)
These reactions are usually resolved within a few days to one week.
RARE ADVERSE EVENTS
In some cases more serious adverse events have been reported, but these are rare. These reported reactions include:
* Persistent nodules or lumps under the skin
* Asymmetry
* Localised infection
* Allergic reaction (very rare)
* Swelling/oedema
* Pain
* Granuloma
* Symptoms of visual disturbance
* Deformity
* Scarring/atrophy
* Hypersensitivity
* Pruritus
* Rash
* Muscle disorders and ischemia/ necrosis.
In some cases injection site nodules have occurred early within weeks, or with late onset several months to over one year post-injection.
with inflammation or discoloration.
In some cases, the nodules were reported to resolve spontaneously or following treatment, but may have a prolonged time or may need surgical excision. Isolated rare cases of vision abnormalities including blindness have been reported following injection of Sculptra® into the temple area, periorbital areas or cheek.
During your treatment a topical anaesthetic cream might be used to provide pain relief, but this is not necessarily required.
The Sculptra treatment may last for up to 2 years depending on the area treated and the technique used but this period may vary, either longer or shorter. Follow-up treatment can help maintain the desired correction.
PRECAUTIONS FOR USE LIDOCAINE: Sculptra may be reconstituted with Lidocaine
Ask Sknject for guidance in case of
• Known hypersensitivity, allergy to lidocaine and/or local anaesthetics of the amide type;
• Athletes: Lidocaine can induce a positive reaction to anti-doping tests;
• Heart disease and/or patient under treatment for heart disease (beta-blockers).
Inform the clinic about your situation and we therefore recommend that you do not have this treatment if you have any of the following.
• Any chronic skin diseases (herpes, acne, rosacea).
• Any complications after surgery.
• Any other adverse reactions.
CONTRAINDICATIONS
* Pregnant or breastfeeding women and children - over 18 years of age only
* In case of inflammatory or infected skin conditions in the area to be treated, or close to this area.
* History of hypersensitivity to any of the components of the injected products (hyaluronic acid, lidocaine, other local anesthetics, one of the ingredients of the phospate buffer supplement*), anaphylactic shock or severe allergy.
* History of autoimmune disease or diseases that affect the immune system (type I diabetes, polyarthritis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, thyroid disorder, scleroderma, inflammatory bowel diseases, lupus, multiple sclerosis, haemorrhagic recto colitis and/or hepatocellular diseases.
* People with epilepsy or porphyria.
* Unhealed skin alterations. Inflammation or infection of the skin at the time of treamtnet.
* Injection of permanent products (silicone, acrylic polymers, dextran).
* Untreated infectious periodontitis, pulpitis, cellulitis of dental or ENT origin, dental abscesses untreated not treated or treated less than a week ago.
* In association with a peeling, laser treatment or ultrasonic type treatment.
* For treatments or areas of the body in which the product is not indicated.
Sculptra may not be suitable for individuals who:
Always disclose your full medical history and current medications prior to treatment.
AFTERCARE ADVICE
Copyright © 2023 SKNJECT - All Rights | Reserved.